High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 3, 2004, Pages 591-597

  Nakamura, Yu ^a   Koh, Motoasa ^a   Miyoshi, Eiji ^b   Ida, Osamu ^c   Morikawa, Masayuki ^a   Tokuyama, Akihiro ^a   Nagano, Tatsuji ^a   Honda, Yoshiharu ^c   Iida, Junzo ^a   Yamamoto, Kunya ^d   Minami, Naoki ^e   Kasahara, Akinori ^b   Hirai, Motoharu ^f   Hayashi, Norio ^b   Kishimoto, Toshifumi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shichiyama Hospital   (Japan)

^d Tarumi Hospital   (Japan)

^e Shimoichi Hospital   (Japan)

^f Akitsu Kohnoike Hospital   (Japan)

Author keywords

Abuse; Alcohol; HCV; Hepatitis; Hepatitis virus C; ICD; Inpatient; International classification and diseases; Japan; Prevalence; Schizophrenia

Indexed keywords

HEPATITIS C ANTIBODY;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNE SYSTEM; JAPAN; MALE; PREVALENCE; PSYCHIATRIC DEPARTMENT; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADULT; AGE FACTORS; ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; BLOOD DONORS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INPATIENTS; JAPAN; MALE; SCHIZOPHRENIA; SEX CHARACTERISTICS; SUBSTANCE-RELATED DISORDERS;

EID: 11144356350     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.01.018     Document Type: Article

References (21)

1. Alter M.J. The detection, transmission, and outcome of hepatitis C virus infection. Infect. Agents Dis. 2:1993;155-166.
2. Chang T.T., Lin H., Yen Y.S., Wu H.L. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan. J. Med. Virol. 40:1993;170-173.
3. Chien D.Y., Choo Q.L., Tabrizi A., Kuo C., McFarland J., Berger K., Lee C., Shuster J.R., Nguyen T., Moyer D.L., Tong M., Furuta S., Omata M., Tegtmeier G., Alter H., Schiff E., Jeffers L., Houghton M., Kuo G. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10011-10015.
4. Cividini A., Pistorio A., Regazzetti A., Cerino A., Tinelli C., Mancuso A., Ribola M., Galli M.L., Agnusdei A., Leone M., Silini E., Mondelli M.U. Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J. Hepatol. 27:1997;455-463.
5. Dobmeier M., Frick E., Frank S., Franke C., Wolfersdorf M. Schizophrenic psychosis: a contraindication for treatment of hepatitis C with interferon alpha? Pharmacopsychiatry. 33:2000;72-74.
6. Garcia-Pares G., Domenech C., Gil M. Psychosis induced by interferon-alpha. Psychosomatics. 43:2002;428-429.
7. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo W.S., Lee C., Berger K., Shuster J.R., Overy L.R., Bradley W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
8. Lavanchy D. Hepatitis C: public health strategies. J. Hepatol. 31(Suppl. 1):1999;S146-S151.
9. Memon M.I., Memon M.A. Hepatitis C: an epidemiological review. J. Viral Hepatitis. 9:2002;84-100.
10. Mohsen A.H., Group T.H. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut. 48:2001;707-713.
11. Nalpas B., Thiers V., Pol S., Driss F., Thepot V., Berthelot P., Brechot C. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J. Hepatol. 14:1992;381-384.
12. Nozaki O., Takagi C., Takaoka K., Takata T., Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin. Neurosci. 51:1997;175-180.
13. Oshita M., Hayashi N., Kasahara A., Hagiwara H., Mita E., Naito M., Katayama K., Fusamoto H., Kamada T. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;1115-1120.
14. Regev A., Jeffers L.J. Hepatitis C and alcohol. Alcohol., Clin. Exp. Res. 23:1999;1543-1551.
15. Renault P.F., Hoofnagle J.H., Park Y., Mullen K.D., Peters M., Jones D.B., Rustgi V., Jones E.A. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147:1987;1577-1580.
16. Rosenberg S.D., Goodman L.A., Osher F.C., Swartz M.S., Essock S.M., Butterfield M.I., Constantine N.T., Wolford G.L., Salyers M.P. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am. J. Public Health. 91:2001;31-37.
17. Sawayama Y., Hayashi J., Kakuda K., Furusyo N., Ariyama I., Kawakami Y., Kinukawa N., Kashiwagi S. Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Dig. Dis. Sci. 45:2000;351-356.
18. Tanaka H., Tsukuma H., Hori Y., Nakade T., Yamano H., Kinoshita N., Oshima A., Shibata H. The risk of hepatitis C virus infection among blood donors in Osaka, Japan. J. Epidemiol. 8:1998;292-296.
19. Verbaan H., Andersson K., Eriksson S. Intravenous drug abuse-the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand. J. Gastroenterol. 28:1993;714-718.
20. World Health Organization, 1992. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research.
21. Zoulim F. Hepatitis C virus infection in special groups. J. Hepatol. 31(Suppl. 1):1999;S130-S135.